Automated Compound Storage and Retrieval System
自动化化合物存储和检索系统
基本信息
- 批准号:10415712
- 负责人:
- 金额:$ 74.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-15 至 2024-04-14
- 项目状态:已结题
- 来源:
- 关键词:AirBar CodesBiologyBiotechnologyCategoriesChemicalsCollectionCommunitiesEffectivenessEnsureEnvironmentEquipmentFee-for-Service PlansFundingGrowthIndividualInformation ManagementInstitutionLaboratoriesLibrariesLife ExpectancyManagement Information SystemsMissionModelingMolecular BankPharmaceutical PreparationsPharmacologic SubstanceResearchResearch PersonnelRetrievalSamplingServicesSiteSourceSpeedSystemTemperatureTimeTranslational ResearchTubeUnited States National Institutes of HealthUniversitiesUpdateVendorVial deviceapplication programming interfaceclinically relevantdrug discoveryhigh throughput screeninglead optimizationpre-clinicalprogramsscreeningscreening servicestool
项目摘要
PROJECT SUMMARY/ABSTRACT
Vanderbilt University is requesting funds for the purchase of a Hamilton Verso M2 to replace our obsolete Brooks
Universal Store (Unistore). The current system was purchased in 2008 through funding from the NIH's Molecular
Library Screening Center Network (MLSCN) and has since provided compound management services to
Vanderbilt investigators performing chemical biology research. The Unistore is a cornerstone of the Vanderbilt
High-throughput Screening (VHTS) Core providing a long-term storage environment, rapid retrieval, and tracking
mechanism for each compound sample, whether in a tube or multi-well plate. This has enabled our institution to
operate on par with biotech and pharmaceutical companies in terms of quality and effectiveness. The VHTS
Unistore holds approximately 200,000 0.7mL tubes, 2,500 4-mL vials, and 7,000 384-well plates - totaling over
2.5 million samples. These samples are categorized as large, chemically diverse screening collections, libraries
of known biologically active compounds, and project-specific compounds. The former two represent the majority
of the samples and are available to any Vanderbilt researcher as a fee-for-service distribution. This service
dovetails to the HTS screening services that span early discovery (e.g. tool compound discovery) and
translational (e.g. discovery of new clinically-relevant activity of known drugs) projects. The third category
(project-specific compounds) are compounds associated with specific, investigator-driven hits-to-leads and lead
optimization preclinical drug discovery projects. Currently, samples from 111 such projects are managed through
our system. Over the past five years, an average of 20,170 individual samples and 1,064 compound plate
replications per year were distributed to investigators. The ability to quickly, efficiently and effectively support the
demands of the Vanderbilt research community critically depends on our automated, environmentally controlled
compound storage and retrieval system with integrated laboratory information management (LIMS) system.
Although the Unistore has been an outstanding piece of equipment, it is well past its life expectancy and requires
extensive on-site vendor support. The availability of vendor support is increasingly limited as Brooks introduces
newer models. Replacement of the system is crucial to ongoing NIH-funded, as well as emerging, research
programs aimed at advancing basic and early translational research. We are requesting funds for a new
automated compound storage and retrieval system that will serve Vanderbilt through the next decade. Mission
critical features that the Verso will provide include 1) 2-D barcode level tracking of tube samples, 2) 1-D barcode
level tracking of plate samples, 3) environmental control with a dry air source and -20 °C redundant compressor
temperature control, 4) high-speed tube picking, 5) storage capacity library growth, and 6) an application program
interface (API) allowing streamlined integration with the existing VHTS LIMS. The timely replacement of the
obsolete Brooks system with the updated Verso will ensure continued service to presently funded projects while
providing a means to grow this capability within Vanderbilt.
项目总结/摘要
范德比尔特大学正在申请资金购买一辆汉密尔顿维索M2,以取代我们过时的布鲁克斯
Universal Store(Unistore).目前的系统是在2008年通过NIH的分子生物学基金购买的。
图书馆筛选中心网络(MLSCN),并提供化合物管理服务,
进行化学生物学研究的范德比尔特研究员。Unistore是范德比尔特
高通量筛选(VHTS)核心提供长期储存环境、快速检索和跟踪
每种化合物样品都有一种独特的机制,无论是在试管中还是在多孔板中。这使我们的机构能够
在质量和有效性方面与生物技术和制药公司同等运营。VHTS
Unistore拥有约200,000支0.7 mL试管、2,500支4 mL小瓶和7,000个384孔板-总计超过
2.5百万样本这些样本被归类为大型的化学多样性筛选收集,库
已知的生物活性化合物和特定项目的化合物。前两者代表多数
并提供给任何范德比尔特的研究人员作为一个收费的服务分布。此服务
对HTS筛选服务的总结,涵盖早期发现(例如工具化合物发现),
转化(例如发现已知药物的新临床相关活性)项目。第三类
(项目特定化合物)是与特定的、由制造商驱动的对潜在客户的点击和潜在客户相关的化合物。
优化临床前药物发现项目。目前,来自111个此类项目的样本通过
我们的系统过去五年,平均20,170个单独样品和1,064个复合板
将每年的复制品分发给研究者。快速、高效和有效地支持
范德比尔特研究界的需求主要取决于我们的自动化,环境控制
复合存储和检索系统与集成实验室信息管理(LIMS)系统。
虽然Unistore是一款出色的设备,但它已经超过了预期寿命,需要
广泛的现场供应商支持。随着布鲁克斯推出
更新的模型。该系统的更换是至关重要的正在进行的NIH资助,以及新兴的研究
旨在推进基础和早期转化研究的项目。我们正在申请资金,
自动化合物存储和检索系统,将服务于范德比尔特通过未来十年。使命
Verso将提供的关键功能包括:1)试管样本的二维条形码水平跟踪,2)一维条形码
板样品的水平跟踪,3)使用干燥空气源和-20 °C冗余压缩机的环境控制
温度控制,4)高速挑管,5)存储容量库增长,和6)应用程序
接口(API),允许与现有VHTS LIMS进行简化集成。及时更换
过时的布鲁克斯系统与更新的Verso将确保继续服务于目前资助的项目,
提供了一种在范德比尔特内部发展这种能力的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joshua A. Bauer其他文献
Refining breast cancer genetic risk and biology through multi-ancestry fine-mapping analyses of 192 risk regions
通过对 192 个风险区域的多祖先精细定位分析来完善乳腺癌的遗传风险和生物学
- DOI:
10.1038/s41588-024-02031-y - 发表时间:
2025-01-03 - 期刊:
- 影响因子:29.000
- 作者:
Guochong Jia;Zhishan Chen;Jie Ping;Qiuyin Cai;Ran Tao;Chao Li;Joshua A. Bauer;Yuhan Xie;Stefan Ambs;Mollie E. Barnard;Yu Chen;Ji-Yeob Choi;Yu-Tang Gao;Montserrat Garcia-Closas;Jian Gu;Jennifer J. Hu;Motoki Iwasaki;Esther M. John;Sun-Seog Kweon;Christopher I. Li;Koichi Matsuda;Keitaro Matsuo;Katherine L. Nathanson;Barbara Nemesure;Olufunmilayo I. Olopade;Tuya Pal;Sue K. Park;Boyoung Park;Michael F. Press;Maureen Sanderson;Dale P. Sandler;Chen-Yang Shen;Melissa A. Troester;Song Yao;Ying Zheng;Thomas Ahearn;Abenaa M. Brewster;Adeyinka Falusi;Anselm J. M. Hennis;Hidemi Ito;Michiaki Kubo;Eun-Sook Lee;Timothy Makumbi;Paul Ndom;Dong-Young Noh;Katie M. O’Brien;Oladosu Ojengbede;Andrew F. Olshan;Min-Ho Park;Sonya Reid;Taiki Yamaji;Gary Zirpoli;Ebonee N. Butler;Maosheng Huang;Siew-Kee Low;John Obafunwa;Clarice R. Weinberg;Haoyu Zhang;Hongyu Zhao;Michelle L. Cote;Christine B. Ambrosone;Dezheng Huo;Bingshan Li;Daehee Kang;Julie R. Palmer;Xiao-Ou Shu;Christopher A. Haiman;Xingyi Guo;Jirong Long;Wei Zheng - 通讯作者:
Wei Zheng
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer
异常的 FGFR 信号通路介导了 ER+乳腺癌对 CDK4/6 抑制剂的耐药性
- DOI:
10.1038/s41467-019-09068-2 - 发表时间:
2019-03-26 - 期刊:
- 影响因子:15.700
- 作者:
Luigi Formisano;Yao Lu;Alberto Servetto;Ariella B. Hanker;Valerie M. Jansen;Joshua A. Bauer;Dhivya R. Sudhan;Angel L. Guerrero-Zotano;Sarah Croessmann;Yan Guo;Paula Gonzalez Ericsson;Kyung-min Lee;Mellissa J. Nixon;Luis J. Schwarz;Melinda E. Sanders;Teresa C. Dugger;Marcelo Rocha Cruz;Amir Behdad;Massimo Cristofanilli;Aditya Bardia;Joyce O’Shaughnessy;Rebecca J. Nagy;Richard B. Lanman;Nadia Solovieff;Wei He;Michelle Miller;Fei Su;Yu Shyr;Ingrid A. Mayer;Justin M. Balko;Carlos L. Arteaga - 通讯作者:
Carlos L. Arteaga
Joshua A. Bauer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joshua A. Bauer', 18)}}的其他基金
Integrated ImageXpress Micro Confocal High Content Screening System
集成 ImageXpress 微型共焦高内涵筛选系统
- 批准号:
10175498 - 财政年份:2021
- 资助金额:
$ 74.14万 - 项目类别:
Identification of druggable targets for triple-negative breast cancer
三阴性乳腺癌药物靶标的鉴定
- 批准号:
7615211 - 财政年份:2009
- 资助金额:
$ 74.14万 - 项目类别:














{{item.name}}会员




